Listing of Color Additives Exempt From Certification; Beetroot Red
Published Date: 2/6/2026
Rule
Summary
The FDA is giving the green light for beetroot red to be used as a safe food color in most human foods, except for certain USDA products, infant formula, and foods with special color rules. This change starts March 23, 2026, and food makers can now use this natural color without extra certification. If anyone wants to object or ask for a hearing, they must do so by March 9, 2026.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Beetroot Red Approved; No Batch Certification
The FDA listed "beetroot red" as a color additive that may be used to color human foods generally, in amounts consistent with good manufacturing practice, effective March 23, 2026. FDA also concluded batch certification of beetroot red is not necessary, so manufacturers can use this color additive without the color-additive batch certification process.
Use Restricted in Certain Foods
Beetroot red may not be used to color products regulated by the U.S. Department of Agriculture (meat, poultry, egg products under the Federal Meat Inspection Act, Poultry Products Inspection Act, or Egg Products Inspection Act), infant formula, or foods with standards of identity under section 401 of the FD&C Act, unless those standards specifically authorize added color. This restriction is effective March 23, 2026.
Mandatory Heavy Metal Specifications
Beetroot red must meet FDA specifications: lead not more than 0.15 mg/kg (0.15 ppm), arsenic not more than 0.05 mg/kg (0.05 ppm), mercury not more than 0.01 mg/kg (0.01 ppm), and cadmium not more than 0.05 mg/kg (0.05 ppm). These specifications apply to the color additive as of March 23, 2026.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-06478 — Determination of Regulatory Review Period for Purposes of Patent Extension; VYLOY
The FDA has officially set the review period for VYLOY, a human biological product, so its patent holder can apply for extra patent time. This affects the company behind VYLOY, giving them a chance to extend their patent protection and potentially boost profits. If anyone thinks the dates are wrong or wants to challenge the company’s review speed, they must act by June 2 or September 30, 2026.
2026-06481 — Determination of Regulatory Review Period for Purposes of Patent Extension; HYMPAVZI
The FDA has set the official review period for HYMPAVZI, a new human biological product, so its patent holder can apply for extra patent time. This affects the company behind HYMPAVZI and anyone interested in patent extensions. If you think the dates are wrong or want to challenge the company’s diligence, you have until June 2 or September 30, 2026, to speak up—potentially impacting patent length and market exclusivity.
2026-06480 — Determination of Regulatory Review Period for Purposes of Patent Extension; EMRELIS
The FDA has officially set the review period for EMRELIS, a medicine patent, so the patent owner can apply for extra protection time. If anyone thinks the dates are wrong, they have until June 2, 2026, to speak up. Also, people can challenge whether the patent owner was diligent during the review by September 30, 2026. This affects patent holders and could impact how long they keep exclusive rights to their product.
2026-06479 — Determination of Regulatory Review Period for Purposes of Patent Extension; ENFLONSIA
The FDA has set the official review period for ENFLONSIA, a human biological product, so its patent holder can apply for extra patent time. This affects the company behind ENFLONSIA and anyone interested in patent rules. If you think the dates are wrong or want to challenge the company’s review speed, you have until June 2 or September 30, 2026, to speak up—potentially impacting patent length and market exclusivity.
2026-06477 — Determination of Regulatory Review Period for Purposes of Patent Extension; ENCELTO
The FDA has officially set the review period for ENCELTO, a medicine patent, so the company can apply to extend its patent protection. This affects the drug maker by potentially giving them more time to exclusively sell ENCELTO, which can mean more money. If anyone thinks the dates are wrong or the company wasn’t diligent, they have until June 2 or September 30, 2026, to speak up.
2026-06483 — Determination of Regulatory Review Period for Purposes of Patent Extension; INJECTAFER
The FDA has officially set the review period for INJECTAFER, a drug patent up for extension. This means the company can apply to extend their patent protection, potentially keeping their exclusive rights longer and impacting competition and pricing. If anyone thinks the dates are wrong or the company wasn’t diligent, they can speak up by June 2 or September 30, 2026.
Previous / Next Documents
Previous: 2026-02311 — Improving the Effectiveness of the Robocall Mitigation Database; CORES Registration System
Starting February 5, 2026, phone companies and service providers must follow new rules to keep the Robocall Mitigation Database accurate and up-to-date. These changes include an annual check-in to confirm their info by March 1, 2026, helping fight annoying robocalls better. This means less spam calls for everyone and smoother phone service for providers, with no extra costs announced.
Next: 2026-02314 — Listing of Color Additives Exempt From Certification; Spirulina Extract
The FDA is giving a green light to use spirulina extract as a natural food color in most human foods, with safer limits on heavy metals like lead and mercury. This change helps food makers use a vibrant, plant-based color while keeping products safer. The new rules kick in on March 23, 2026, and anyone can raise concerns by March 9, 2026.
Take It Personal
Get Your Personalized Policy View
Start a Free Government Policy Watch to see how policy affects your household, then upgrade to PRIA Full Coverage for year-round monitoring.
Already have an account? Sign in